Drawing for FOCALYX

USPTO serial 99041698

FOCALYX

Reviewed by CopyMark Law Group

Reg. 8099234Status 700Registered
Filing date
Status date
Registration date
Jan 13, 2026
Examiner
LAMONT,MIAH ROSENBERG
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with FOCALYX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paul D. Bianco

Paul D. Bianco Fleit Intellectual Property Law21355 East Dixie HighwaySuite 115Miami, FL 33180

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer application software for mobile phones, namely, software for providing and tracking information relating to health and wellness, namely, for tracking cancerous lesions; Downloadable computer application software for mobile phones, namely, software for viewing personal health data relating to cancerous lesions; Downloadable computer application software for mobile phones, namely, software for assisting users with managing their health by enabling users to transmit data and information between health care professionals and patients; Downloadable computer application software for mobile phones, namely, software for monitoring diagnostic and treatment characteristics of men diagnosed with prostate cancer; Downloadable computer application software for mobile phones, namely, software for obtaining resources and guidance related to prostate cancer; Downloadable and/or recorded software for operating medical imaging apparatus; Downloadable and/or recorded computer programs for use in cancer diagnosis and treatment; Downloadable and/or recorded software for use with diagnostic apparatus for the detection of cancer; Downloadable and/or recorded medical software for use with urological imaging systems; Downloadable and/or recorded medical software for managing medical imaging apparatus; Downloadable and/or recorded medical software for use in the diagnosis and treatment of cancer; Downloadable and/or recorded medical software for the creation or transmission of images, video or data relating to a medical procedure; Downloadable and/or recorded medical software for use in identifying suspicious tissue in the prostate, creating a three-dimensional model of the prostate and providing real-time tracking of biopsy needle locations; Downloadable and/or recorded imaging software that uses ultrasound and three-dimensional images to provide real-time imaging of the prostate, nearby anatomical structures, and instruments inserted into the prostate to guide instrument placement; Downloadable and/or recorded software for use in computer-assisted surgical planning; Downloadable and/or recorded software for defining target regions within the prostate in transrectal ultrasound images and diagnostic/planning images; Downloadable and/or recorded software that reproduces and supplements the visual information provided by transrectal ultrasound images, and superimposes a graphical representation of one or more target regions on to the reproduced images; Downloadable and/or recorded software that provides 2D and 3D image visualization features, namely, the ability to review images, generate multi-planar views, annotate images, and identify and record the locations of instruments inserted during a medical procedure; Downloadable and/or recorded software that performs three-dimensional (3D) reconstruction of digitized transrectal ultrasound imagesACTIVEJan 1, 2019
044Medical imaging services; Medical diagnosis and treatment of prostate cancer; Medical analysis services for the diagnosis of cancer; Providing cancer screening services; Consulting services in the field of medical imaging regarding the use and operation of medical imaging apparatus; Medical evaluation of prostate cancer; Health care services for treating prostate cancer; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Providing a website via a global computer network featuring information in the fields of health, cancer, cancer recovery and survival; Health care services, namely, diagnostic and treatment procedures of the prostate; Healthcare services featuring focal therapy for cancer, targeted therapy for cancer, image- guided cancer diagnostics, image-guided focal cancer treatment, and focal cancer therapy treatment with organ preservation; healthcare services featuring focal treatment of cancer, targeted treatment of cancer, image-guided cancer diagnostics, image-guided focal cancer treatment, and focal cancer treatment with organ preservationACTIVEJan 1, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 25, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 25, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 19, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 29, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2025DOCKASSIGNED TO EXAMINER—
Jul 13, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 13, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 14, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 14, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance